FDA Approves GW Pharmaceuticals CBD Drug Epidiolex
Let's Look At Epidiolex Compared To Full Spectrum CBD Oil.
We have an endocannabinoid system. Cannabis and humans are symbiotic and that is rooted in nature.
The impact the approval of Epidiolex will have on the global CBD market is unclear. GW Pharmaceutical's Epidiolex is a pharmaceutical-grade version CBD oil, with the primary goal to treat children with epilepsy. Who wouldn't want to treat children with epilepsy!?!? The U.S. Food and Drug Administration approved GW Pharmaceutical's new epilepsy drug, the first ever based on CBD (cannabidiol) which is expected to launch this fall. Results from trials of the drug showed it reduced the amount of seizures significantly in patients with Lennox-Gastaut syndrome and Dravet syndrome. This is great news for the image of CBD and medical cannabis as a whole. We think the greatest takeaway from this is real recognition by the federal government, for the first time, there are medicinal benefits from the cannabis plant! Also, Epidiolex's move to a lower drug class should change how the government views CBD and medicinal cannabis. Hopefully this is the kick in the keister needed to change this Schedule 1 drug nonsense.
CBD is one of more than 100 chemicals found in hemp & cannabis. Epidiolex is made from a purified form of CBD. It's a strawberry flavored syrup containing a pharmaceutical-grade version CBD oil, which is not a full spectrum product. There are many parents of children with epilepsy and adult patients having accepted CBD as a medical alternative, but that has not necessarily translated over to the professional medical community. Obviously an FDA approved CBD drug will open the door to their thought process and ignorance of CBD. Hopefully it will also allow them to be more open minded to the cannabis plant as a whole, especially a full spectrum whole plant treatment. The medical community isn't necessarily taught, trained or "programmed" to focus on the more natural option. We can tell you from first hand experience that full spectrum CBD oil works wonders on people with epilepsy. So in that sense, we are thrilled by the FDA approval of a CBD related drug.
Physicians say it’s important to have a consistent, government-regulated version, which I'm not going to argue with. What I can say is in working with medical cannabis and CBD for 10 years I have never seen either a synthetic version of the plant (marinol) or a purified version (CBD Isolate) out perform a full spectrum cannabinoid product. Epidiolex has its origin rooted in good treatment intentions, treating children with epilepsy. We have collectively done this for years and there is nothing more rewarding. What we are fearful of is the beginning of a corporate takeover of this plant. Which begs the question, does the federal government and pharmaceutical companies always know whats best? Especially when it comes to all natural homeopathic treatments, which full spectrum hemp extraction products absolutely are. Physicians say it’s important to have a consistent, government-regulated version, that is hard to argue. Safety for our children comes first. We have treated epileptic children with amazing results, but not everyone is qualified nor should they do this. It's up to the consumer to decide and results speak for themselves.
This is Corporate America, so GW has certainly been busy over the last 5 years or so. They've studied the drug in more than 500 children and adults with hard-to-treat seizures. They have also barreled through countless legal blockades that have thwarted the study of cannabis for decades, a definitive positive progression for hemp, cannabis and CBD. Many physicians are expressing their comfort in the cleaner, regulated and consistent Epidiolex product. This absolutely sounds great in theory and its how the medical profession is trained. But, if you have been working with this plant in helping others you know its not always that simple. There are thousands of strains and varietals of the cannabis plant each potentially having differing effects on the patients using them for ailments. Countless combinations and concentrations of cannabinoids (thc, thca, thcv, cbd, cbn, cbg), flavinoids, terpenes and other compounds are available to us in this plant. For some it takes weeks, months or years to dial in the strain, ratios, cannabinoids, concentrations etc.. that works best for them. This is called the "Entourage Effect", all of the elements of the plant working together. Many feel it's why 99.9% purified CBD isolate is not always the best choice. Cannabis is a complex plant with over 400 chemical entities of which more than 60 of them are cannabinoid compounds. As humans we have a matching endocannabinoid system. Cannabis and humans are symbiotic and for most that is not easy to understand. This simple fact has been hidden from us. Believe it or not, majority of doctors don't even know we have an endocannabinoid system. How nuts is that!!!! Its just something that is not taught nor talked about, not even in medical school.
Some would say the approval is a milestone that could spur more research into a "drug" that remains illegal under federal law, despite growing legalization for recreational and medical use. Some will feel threatened, feeling that this is the first step in big pharma cornering the market on CBD. It's inevitable that more cannabinoids will be studied, patented and locked down by these companies. We just hope there will always be a place for the little guy. The folks that have been cultivating, processing and treating others with this plant for centuries.